^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Droplex c-Met Exon14 Skipping Test

    Company:
    Gencurix
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    Twitter
    Dropplex c-Met Exon14 Skipping Test is for non- small cell lung cancer (NSCLC, Non-Small Cell Lung Cancer) patients, in the presence of cMET Exon14 Skipping mutation by using RNA extracted from the patient's FFPE and whole blood. The test results can help with the selection of patients receiving ABN401, a targeted treatment.
    Cancer:
    Non Small Cell Lung Cancer
    Gene:
    MET (MET proto-oncogene, receptor tyrosine kinase)
    Drug:
    ABN401
    Method:
    PCR